Publications by authors named "Hae-In Lim"

Claim this Profile
S
Sd-021, derivatives of decursin, inhibits tumorigenesis in NSCLC by inhibiting the EGFR/STAT3 signaling pathway.
Hyun-Ha Hwang, Jeong-Hui Je, Hyeong-Chan Lee, Ji-Sung Yoo, Taehyoun Kim, Hae-In Lim

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The combination of SH003 and DTX induces cytotoxic cell infiltration in anti-PD1 resistant lung cancer.
Yu-Jeong Choi, Sang-Eun Lee, Daeun Kim, Hae-In Lim, Da Kyung Choi

Cancer Immunol Immunother· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncovering the anti-cancer mechanism of cucurbitacin D against colorectal cancer through network pharmacology and molecular docking.
Hae-In Lim, Ga Yoon Kim, Yu-Jeong Choi, Kangwook Lee, Seong-Gyu Ko

Discov Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer.
Kangwook Lee, Yu-Jeong Choi, Hae-In Lim, Kwang Jin Cho, Nuri Kang

BMC Complement Med Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis